Cargando…

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden

A temporal increase in non-B subtypes has earlier been described in Sweden by us and we hypothesized that this increased viral heterogeneity may become a hotspot for the development of more complex and unique recombinant forms (URFs) if the epidemics converge. In the present study, we performed subt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neogi, Ujjwal, Siddik, Abu Bakar, Kalaghatgi, Prabhav, Gisslén, Magnus, Bratt, Göran, Marrone, Gaetano, Sönnerborg, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527090/ https://www.ncbi.nlm.nih.gov/pubmed/28744024 http://dx.doi.org/10.1038/s41598-017-06860-2

Ejemplares similares

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades
por: Neogi, Ujjwal, et al.
Publicado: (2014)

HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries
por: Esbjörnsson, Joakim, et al.
Publicado: (2016)

Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003–2010
por: Karlsson, Annika, et al.
Publicado: (2012)

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
por: Häggblom, Amanda, et al.
Publicado: (2017)

Trends in Antiretroviral Therapy and Prevalence of HIV Drug Resistance Mutations in Sweden 1997–2011
por: Bontell, Irene, et al.
Publicado: (2013)

All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
por: Elvstam, Olof, et al.
Publicado: (2020)

The molecular epidemiology of HIV-1 in Sweden 1996 to 2022, and the influence of migration from Ukraine
por: Weibull Wärnberg, Anna, et al.
Publicado: (2023)

Emergence of unique recombinant forms (URFs) in Indian HIV-1 epidemic: data from nationwide clinical cohort between 2007 and 2011
por: Neogi, U, et al.
Publicado: (2012)

Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing
por: Telele, Nigus Fikrie, et al.
Publicado: (2018)

A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort
por: Telele, Nigus Fikrie, et al.
Publicado: (2019)

Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in Sweden
por: de Coninck, Zaake, et al.
Publicado: (2018)

Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution
por: Zhang, Wang, et al.
Publicado: (2018)

Pattern of microbial translocation in patients living with HIV-1 from Vietnam, Ethiopia and Sweden
por: Abdurahman, Samir, et al.
Publicado: (2014)

P20-05. Emergence of HIV-1 circulatory recombinant forms (CRFs) and unique recombinant forms (URFs) in North India: functional and pathogenic implications
por: Neogi, U, et al.
Publicado: (2009)

Family-Joining: A Fast Distance-Based Method for Constructing Generally Labeled Trees
por: Kalaghatgi, Prabhav, et al.
Publicado: (2016)

Corrigendum to: Family-joining: A fast distance-based method for constructing generally labeled trees
por: Kalaghatgi, Prabhav, et al.
Publicado: (2020)

Phenotypic co-receptor tropism and Maraviroc sensitivity in HIV-1 subtype C from East Africa
por: Siddik, Abu Bakar, et al.
Publicado: (2018)

Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy
por: Bai, Xiangning, et al.
Publicado: (2021)

Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden
por: Carlander, Christina, et al.
Publicado: (2023)

Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy
por: Zhang, Wang, et al.
Publicado: (2017)

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
por: Ray, Shilpa, et al.
Publicado: (2020)

A5 Near full-length HIV-1 genome sequencing in newly diagnosed individuals in Sweden
por: Andersson, E, et al.
Publicado: (2019)

Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
por: Albert, Jan, et al.
Publicado: (2014)

Long-Term Efficacy of First Line Antiretroviral Therapy in Indian HIV-1 Infected Patients: A Longitudinal Cohort Study
por: Neogi, Ujjwal, et al.
Publicado: (2013)

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
por: Sörstedt, Erik, et al.
Publicado: (2016)

Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
por: Saccon, Elisa, et al.
Publicado: (2021)

Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals
por: Neogi, Ujjwal, et al.
Publicado: (2013)

Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse Subtypes
por: Rogers, Leonard, et al.
Publicado: (2018)

Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90‐90‐90 continuum of HIV care targets
por: Gisslén, M, et al.
Publicado: (2016)

HIV-1 Circulating Recombinant Forms (CRFs) and Unique Recombinant Forms (URFs) in Israel, 2010–2018
por: Wagner, Tali, et al.
Publicado: (2022)

Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy
por: Svärd, Jenny, et al.
Publicado: (2017)

Epistatic Interactions in NS5A of Hepatitis C Virus Suggest Drug Resistance Mechanisms
por: Knops, Elena, et al.
Publicado: (2018)

Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers
por: Zhang, Wang, et al.
Publicado: (2017)

MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors
por: Aralaguppe, Shambhu G., et al.
Publicado: (2019)

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
por: Ambikan, Anoop T, et al.
Publicado: (2022)

Symptomatic Patients without Epidemiological Indicators of HIV Have a High Risk of Missed Diagnosis: A Multi-Centre Cross Sectional Study
por: Brännström, Johanna, et al.
Publicado: (2016)

Recombination Form and Epidemiology of HIV-1 Unique Recombinant Strains Identified in Yunnan, China
por: Li, Lin, et al.
Publicado: (2012)

GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds
por: Singh, Kamal, et al.
Publicado: (2019)

Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
por: Sperk, Maike, et al.
Publicado: (2021)

Maximum likelihood pandemic-scale phylogenetics
por: De Maio, Nicola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5k9j8kl0k75cib74mc24ijb1ei